Header cover image
  • Investing Ideas
  • /
  • Norwegian Pharmaceuticals & Biotech Low Leverage High Rewards

Norwegian Pharmaceuticals & Biotech Low Leverage High Rewards

Results

1

0 new

1 companies

Vistin Pharma

Market Cap: NOK 935.7m

Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.

VISTN

NOK 21.10

7D

1.0%

1Y

-11.0%